Coya Therapeutics (COYA) Operating Expenses (2022 - 2026)

Coya Therapeutics (COYA) has 5 years of Operating Expenses data on file, last reported at $7.9 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 0.55% year-over-year to $7.9 million; the trailing twelve-month figure through Mar 2026 stood at $30.5 million (up 31.69% YoY), and the FY2025 full-year result was $30.5 million, up 46.61% from the prior year.
• Operating Expenses slipped to $7.9 million in Q1 2026, from $10.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $10.0 million in Q4 2025 to a low of $1.7 million in Q1 2022.
• A 5-year average of $4.9 million and a median of $4.2 million in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses retreated 5.57% in 2023 and surged 144.74% in 2025, its largest moves.
• Tracing COYA's Operating Expenses over 5 years: stood at $2.0 million in 2022, then soared by 108.98% to $4.2 million in 2023, then decreased by 2.5% to $4.1 million in 2024, then surged by 144.74% to $10.0 million in 2025, then dropped by 21.01% to $7.9 million in 2026.
• Business Quant data shows COYA's Operating Expenses at $7.9 million in Q1 2026, $10.0 million in Q4 2025, and $6.0 million in Q3 2025.